1. Home
  2. ASRT vs SNAL Comparison

ASRT vs SNAL Comparison

Compare ASRT & SNAL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ASRT
  • SNAL
  • Stock Information
  • Founded
  • ASRT 1995
  • SNAL 2000
  • Country
  • ASRT United States
  • SNAL United States
  • Employees
  • ASRT N/A
  • SNAL N/A
  • Industry
  • ASRT Biotechnology: Pharmaceutical Preparations
  • SNAL Computer Software: Prepackaged Software
  • Sector
  • ASRT Health Care
  • SNAL Technology
  • Exchange
  • ASRT Nasdaq
  • SNAL Nasdaq
  • Market Cap
  • ASRT 85.1M
  • SNAL 69.1M
  • IPO Year
  • ASRT 1997
  • SNAL 2022
  • Fundamental
  • Price
  • ASRT $0.83
  • SNAL $2.27
  • Analyst Decision
  • ASRT Strong Buy
  • SNAL
  • Analyst Count
  • ASRT 4
  • SNAL 0
  • Target Price
  • ASRT $3.19
  • SNAL N/A
  • AVG Volume (30 Days)
  • ASRT 634.7K
  • SNAL 103.4K
  • Earning Date
  • ASRT 03-10-2025
  • SNAL 11-13-2024
  • Dividend Yield
  • ASRT N/A
  • SNAL N/A
  • EPS Growth
  • ASRT N/A
  • SNAL N/A
  • EPS
  • ASRT N/A
  • SNAL 0.08
  • Revenue
  • ASRT $125,763,000.00
  • SNAL $86,822,973.00
  • Revenue This Year
  • ASRT N/A
  • SNAL $39.43
  • Revenue Next Year
  • ASRT $1.84
  • SNAL $26.12
  • P/E Ratio
  • ASRT N/A
  • SNAL $30.03
  • Revenue Growth
  • ASRT N/A
  • SNAL 82.23
  • 52 Week Low
  • ASRT $0.73
  • SNAL $0.52
  • 52 Week High
  • ASRT $1.80
  • SNAL $2.43
  • Technical
  • Relative Strength Index (RSI)
  • ASRT 42.81
  • SNAL 65.05
  • Support Level
  • ASRT $0.78
  • SNAL $1.75
  • Resistance Level
  • ASRT $0.94
  • SNAL $2.04
  • Average True Range (ATR)
  • ASRT 0.05
  • SNAL 0.23
  • MACD
  • ASRT -0.00
  • SNAL 0.01
  • Stochastic Oscillator
  • ASRT 29.56
  • SNAL 76.47

About ASRT Assertio Holdings Inc.

Assertio Holdings Inc is a pharmaceutical company. It is engaged in providing solutions to advance patient care in the areas of neurology, orphan and specialty medicines. The company markets three FDA-approved products for various neurological conditions including Gralise, tablets for the management of postherpetic neuralgia; CAMBIA, for acute treatment of migraine attacks with or without aura in adults of age or older; and Zipsor, liquid-filled capsules for relief of mild to moderate pain.

About SNAL Snail Inc.

Snail Inc is a global independent developer and publisher of interactive digital entertainment for consumers around the world, with a premier portfolio of premium games designed for use on a variety of platforms, including consoles, PC's, and mobile devices. The geographic presence of the company is in the United States and the International market, where the majority of its revenue comes from the United States.

Share on Social Networks: